Pharmaceutical Water Market Size, Share, and Trends 2024 to 2034

Pharmaceutical Water Market Size, Share By Product (HPLC Grade Water, and Water for Injection), By Application (Pharmaceutical & Biotechnology Companies and Academics & Research Laboratories) - Global Industry Analysis, Growth, Trends Analysis, Segment Forecasts, Regional Outlook 2024 - 2033

  • Last Updated : December 2022
  • Report Code : 1179
  • Category : Healthcare

The global pharmaceutical water market size was valued at USD 38.69 billion in 2023 and is predicted to hit USD 95.14 billion by 2033 with a CAGR of 9.2% from 2024 to 2033.

Pharmaceutical Water Market Size 2024 to 2033

Key Takeaways

  • North America led the global market with the highest market share of 34.8% in 2023.
  • Asia-Pacific is estimated to expand at the fastest CAGR of 10.3% from 2024 to 2033.
  • By type, the water for injection segment captured the biggest revenue share of 79.07% in 2023.
  • By type, the HPLC grade water segment has held the revenue share of 20.93% in 2023.
  • By type, the water for injection segment is anticipated to expand at the fastest CAGR of 10.2% during the projected period.
  • By application, the pharmaceutical & biotechnology companies segment held the highest market share of 57.64% in 2023 and it is projected to expand at the fastest CAGR of 10.2% over the projected period.

Key market Insights:

High purity water is a vital component in the production process of vital lifesaving drugs. The ongoing demand for high quality water is the sole major driver for the progress of the pharmaceutical water market. Pharmaceutical corporations are on expedition to save cost and retain their profit margins. The saving measures have a trickle-down effect that is strictly affecting the water for pharmaceuticals market. The novel tendency is for pharmaceutical consumers to procure the lowermost cost systems. This consequences in profit margin attrition for the water technology suppliers and equipment providers. They have to suggestively lower their prices in an effort to success bids and stay competitive.

Pharmaceutical Water Market in the U.S. 2024-2033

The U.S. pharmaceutical water market size was valued at USD 6.34 billion in 2023 and is estimated to reach around USD 16.12 billion by 2033, growing at a CAGR of 9.6% from 2024 to 2033.

U.S. Pharmaceutical Water Market Size 2024 to 2033


North America is Estimated to be Garner Major Chunk of Pharmaceutical Water Market

The research report covers key trends and prospects of Pharmaceutical Water products across different geographical regions including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America seized major stake of the pharmaceutical water market in 2022. Occurrence of important companies and development strategies accepted by these players are the major influences propelling the growth of pharmaceutical water market in the region.

Emerging countries embrace  the majority of prospects for pharmaceuticals water market, with China leading the control. China is expected to be the fastest developing region for outlay in the pharmaceuticals water market. Investments of USD 68.3 million in 2014 are set to increase to USD 130.7 million in 2018. The level of development is being motivated by the rising expectation of progressively large and prosperous population in China, which will consequence in augmented spending on upgraded pharmaceutical and healthcare products. For water-associated corporations, the prospects present in projects presented by international pharmaceutical firms manufacturing in the region. Further, in India, investment in pharmaceutical water will also perceive striking progress during years to come.

Pharmaceutical Water Market Share, By Region, 2023 (%)
  • Canada pharmaceutical water market was valued at USD 4.41 billion in 2023 and it is growing at a CAGR of 9.3% from 2024 to 2033.
  • Germany pharmaceutical water market size was estimated at USD  3.47 billion in 2023 and it is growing at a CAGR of 10.1% from 2024 to 2033.

Pharmaceutical Water Market Scope

Report Highlights Details
Growth Rate from 2024 to 2033 CAGR of 9.2%
Market Size in 2023 USD 38.69 Billion
Market Size by 2033 USD 95.14 Billion
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered Type, Application, Region
Companies Mentioned B. Braun Melsungen AG, Merck KGaA, Thermo Fisher Scientific, Inc., Baxter International, Inc., Intermountain Life Sciences, Cytiva (Danaher), Standard Reagents, Pvt. Ltd., FUJIFILM Irvine Scientific, CovaChem, LLC, Pfizer, Inc and Fresenius Kabi AG.

 

Crucial factors accountable for market growth are:

  • Rising burden of diabetes among the obese and geriatric population
  • Rise of biopharmaceutical and generic injectable drugs sectors
  • Upsurge in responsiveness for routine checkup and diagnosis

Type Insights

The water for injection segment dominated the pharmaceutical water market in 2023. Water for injection (WFI) is a critical component in pharmaceutical manufacturing processes, particularly for the formulation of parenteral drugs such as injectables, infusions, and sterile solutions. Regulatory agencies such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and other international regulatory bodies mandate strict quality standards for WFI to ensure product safety, efficacy, and compliance with Good Manufacturing Practices (GMP).

Pharmaceutical Water Market Revenue, By Type, 2022-2030 (USD Bn)

By Type 2022 2023 2027 2030
HPLC Grade Water 7.29 8.10 11.84 15.24
Water for Injection 27.41 30.60 45.56 59.49

 

Application Insights

The pharmaceutical & biotechnology companies segment led the market with the largest share in 2023. Pharmaceutical water is a critical component in the manufacturing of pharmaceutical products, as it is used in various stages of production, including formulation, cleaning, and quality control. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have stringent requirements for the quality and purity of water used in pharmaceutical manufacturing. Pharmaceutical and biotechnology companies have the expertise, resources, and infrastructure to meet these regulatory standards and ensure the production of high-quality pharmaceutical water.

Pharmaceutical Water Market Revenue, By Application, 2022-2030 (USD Bn)

By Application 2022 2023 2027 2030
Pharmaceutical & Biotechnology Companies 19.97 22.30 33.25 43.44
Academics & Research Laboratories 14.72 16.39 24.15 31.29


Pharmaceutical Water Market Players

With the industry assuming regulatory fluctuations across the globe on micropollutants, pharmaceutical corporations are seeking to get forward of the micropollutants issues. Water technology suppliers have prospect to profit from the necessity for leading-edge systems that can deal micropollutants, and want to recognize the suitable technology combinations to attain the most well-organized and cost-effective outcomes. Chief competitors contending in global Pharmaceutical Water market are as follows:

  • Baxter International, Inc.
  • Merck KGaA
  • Braun Melsungen AG
  • Thermo Fisher Scientific, Inc
  • Cytiva (Danaher)
  • Fresenius Kabi AG
  • Pfizer, Inc.
  • CovaChem, LLC
  • Intermountain Life Sciences

In order to better recognize the current scenarios of pharmaceutical water sector, and policies adopted by the foremost countries, Precedence Research predicted the future evolution of the Pharmaceutical Water market. This research report embraces complete valuation of the market with the help of wide-ranging qualitative and quantitative perceptions, and forecasts concerning the market. This report bids classifications of market into potential and niche segments. Further, this research study examines market size and its growth trend at global, regional, and country from 2021 to 2033.

Major Market Segments Covered:

By Type

  • HPLC Grade Water
  • Water for Injection

By Application

  • Pharmaceutical & Biotechnology Companies
  • Academics & Research Laboratories

By Geography

    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • United Kingdom
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Southeast Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC
      • North Africa
      • South Africa
      • Rest of Middle East & Africa

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global pharmaceutical water market size valued at USD 38.69 billion in 2023 and is predicted to be worth around USD 95.14 billion by the end of 2033.

The global pharmaceutical water market is representing impressive CAGR of 9.2% during the forecast period 2023 to 2033.

HPLC grade water segment predicted to offer substantial growth.

Pharmaceutical & Biotechnology Companies is expected to dominate the pharmaceutical water market revenue.

North America dominated the global pharmaceutical water market in 2023 and predicted to maintain the trend throughout forecast period.

Principal companies operating in the pharmaceutical water market comprise B. Braun Melsungen AG, Merck KGaA, Thermo Fisher Scientific, Inc., Baxter International, Inc., Intermountain Life Sciences, Cytiva (Danaher), Standard Reagents, Pvt. Ltd., FUJIFILM Irvine Scientific, CovaChem, LLC, Pfizer, Inc andFresenius Kabi AG.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Meet the Team

Deepa Pandey, one of our esteemed authors, plays a crucial role in shaping the high-quality content that defines our research reports. Deepa holds a Master's in Pharmacy with a specialization in Pharmaceutical Quality Assurance, equipping her with an in-depth understanding of the healthcare industry's regulatory, quality, and operational nuances. With 2+ years of experience in market research, Deepa has made

Learn more about Deepa Pandey

With over 14 years of experience, Aditi is the powerhouse responsible for reviewing every piece of data and content that passes through our research pipeline. She is not just an expert—she’s the linchpin that ensures the accuracy, relevance, and clarity of the insights we deliver. Aditi’s broad expertise spans multiple sectors, with a keen focus on ICT, automotive, and various other cross-domain industries.

Learn more about Aditi Shivarkar

Related Reports